|
|
| Product Name: | HPL | | Synonyms: | PLACENTAL LACTOGEN;PLACENTAL LACTOGEN, HUMAN;lactogen from human placenta;LACTOGEN FROM HUMAN PLACENTA 95+%;Choriomammotropin;Choriomammotropin, Chorionic somatotropin, HPL;Chorionic somatotropin;LACTOGEN HUMAN | | CAS: | 9035-54-5 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![HPL Structure]() |
| storage temp. | 2-8°C | | form | lyophilized | | biological source | human |
| Uses | Human placental lactogen (HPL), also called human chorionic somatomammotropin 1, is a polypeptide placental hormone. Its structure and function is similar to that of growth hormone. The gene encoding this protein is localized on human chromosome 17. Recombinant human placental lactogen is a 22.3kDa protein. | | Biological Activity | Human placental lactogen (HPL) modifies the metabolic state of the mother during pregnancy to facilitate the energy supply, glucose supply and growth of the fetus. Studies show th at targeted expression of this protein in transgenic mice lead to an increase in proliferation of β-cells. | | Description | Placental Lactogen Human Recombinant, is a single polypeptide chain containing 199 amino acids and an additional Ala at the N-terminus having a molecular mass of approximately 22.4 kDa.
Placental Lactogen Recombinant is purified by proprietary chromatographic techniques. | | Source | Escherichia Coli | | Background | Placental Lactogen is a polypeptide hormone that is produced by the Syncytiotrophoblasts of the Placenta, also known as chorionic somatomammotropin. It has both GH and Prolactin activities on growth, lactation, and luteal steroid production. In women, placental lactogen secretion begins soon after implantation and increases to 1 g or more a day in late pregnancy. Placental lactogen is also an ins. antagonist.
Placental Lactogen Bovine is also capable of activating human and other heterologous GH receptors but not ruminat GH receptors. |
| | HPL Preparation Products And Raw materials |
|